Accessibility Menu

Incyte(FRA) ICY

Market Cap€22.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€106.40
-1.98%
-2.15Today

Incyte Financials at a Glance

Market Cap

€22.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€4.99K

Net Income (TTM)

€1.38K

EPS (TTM)

€6.73

P/E Ratio

16.13

Dividend

€0.00

Beta (Volatility)

-0.02 (Low)

Price

€106.40

Volume

0

Open

€106.40

Previous Close

€106.40

Daily Range

€106.40 - €106.40

52-Week Range

€69.58 - €115.40

Estimated Earnings Date

N/A

ICY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Incyte

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. The company was founded in April 1991 and is headquartered in Wilmington, DE.

Industry

Biotechnology

Employees

2,844

CEO

William J. Meury

ICY Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

30.39%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

6.20%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€22.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

202.70M

Volume

0

Avg. Volume

34.197

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Incyte Performance Analysis

Incyte annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 3,229,988,54127.8%
20232023-12-31EUR 3,418,366,1675.8%
20242024-12-31EUR 3,920,914,52714.7%
20252025-12-31EUR 4,555,504,56016.2%
Incyte annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.45-60.0%
20232023-12-31EUR 2.4569.0%
20242024-12-31EUR 0.14-94.1%
20252025-12-31EUR 5.683866.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€1.44K

+1.3%

Gross Profit

€1.33K

+1.3%

Gross Margin

92.57%

+1.0%

Market Cap

€22.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€7.06

N/A

Employees

2,844

N/A

Net Income

€503.66

+1.4%

EBITDA

€625.15

+2.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€3.52K

+106.7%

Total Debt

€33.47

+0.9%

Accounts Receivable

€984.17

+1.4%

Inventory

€98.44

+1.4%

Long Term Debt

€24.86

+0.9%

Short Term Debt

€8.61

+0.9%

Return on Assets

23.35%

+1.4%

Return on Invested Capital

14.00%

+2.2%

Free Cash Flow

€427.85

+89.2%

Operating Cash Flow

€438.58

+20.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About ICY

What is the current price of Incyte?

Incyte is trading at €106.40 per share.

What is the 52-week range for Incyte?

Over the past 52 weeks, Incyte has traded between €69.58 and €115.40.

How much debt does Incyte have?

As of the most recent reporting period, Incyte reported total debt of €33.47M.

How much cash does Incyte have on hand?

Incyte reported €3.48B in cash and cash equivalents in its most recent financial results.

What is Incyte’s dividend yield?

Incyte does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.